白细胞端粒长度与卒中、痴呆及晚年抑郁的关联及可调控风险因素的作用
基于英国生物银行356,173名参与者的队列研究显示,较短的白细胞端粒长度与卒中、痴呆及晚年抑郁风险升高相关;高脑健康评分(BCS≥15)可减弱该关联,而孟德尔随机化未发现因果联系。
要点
- 最短端粒三分位者复合结局风险HR 1.11(95%CI 1.08-1.15)。
- 端粒短且BCS低者风险更高,端粒短但BCS高者风险无显著增加。
- 孟德尔随机化未提示端粒长度与这些结局存在因果关系。
核心结论
- 较短白细胞端粒长度与卒中、痴呆及晚年抑郁风险升高相关,但孟德尔随机化未支持因果关联。
研究设计与样本
- 基于英国生物银行的队列研究,纳入356,173名有端粒长度和风险因素数据的参与者,中位年龄56岁,女性占53.69%。
主要发现
- 最短端粒三分位者复合结局HR 1.11(95%CI 1.08-1.15),卒中HR 1.08(95%CI 1.02-1.15),痴呆HR 1.19(95%CI 1.12-1.26),晚年抑郁HR 1.14(95%CI 1.09-1.18)。
- 端粒短且BCS低者复合结局HR 1.11(95%CI 1.07-1.16),卒中HR 1.10(95%CI 1.02-1.19),痴呆HR 1.17(95%CI 1.08-1.28),晚年抑郁HR 1.13(95%CI 1.07-1.19)。
- 最短端粒组中BCS高者任何年龄相关脑疾病风险均无显著增加。
- 孟德尔随机化分析未发现端粒长度与这些结局的因果关联。
关键数值与推荐
- 高BCS定义为≥15,低BCS定义为≤10。
- 端粒长度按三分位分层,最短三分位为暴露组。
临床怎么用
- 较短端粒长度可作为卒中、痴呆及晚年抑郁风险增高的生物衰老标志,但需结合可调控风险因素综合评估。
- 改善可调控风险因素(高BCS)可能减弱端粒长度相关风险,支持生活方式干预在脑健康管理中的潜在价值。
局限性
- 孟德尔随机化未发现因果关联,提示观察性关联可能受残余混杂影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Stroke, dementia, and late-life depression (LLD) are age-related brain diseases that pose significant public health challenges and costs. Leucocyte telomere length (LTL) is a biological aging marker influenced by both genetic and lifestyle factors. The aim of our study was to determine the association between LTL and these diseases. We further investigated whether modifying risk factors of age-related brain disease, as measured using the Brain Care Score (BCS), mitigates LTL associations. METHODS: We analyzed participants from the UK Biobank with available LTL and risk factor information. We examined LTL's associations with stroke, dementia, and LLD, individually and as a composite outcome, using continuous measures and tertile stratification. Disease risks were evaluated through cumulative incidence curves, incidence rates per 1,000 person-years, and adjusted Cox models. Risk comparisons across LTL tertiles were stratified by risk factor profiles, with high BCS (≥15) indicating healthier lifestyle choices and low BCS (≤10) reflecting less optimal lifestyle choices. Mendelian randomization (MR) was used to test causal associations. RESULTS: The study included 356,173 participants (median age 56 years; 53.69% female). Shorter LTL was consistently associated with higher incidence rates across all outcomes. Participants in the shortest LTL tertile had elevated risks of the composite outcome (hazard ratio [HR] 1.11; 95% CI 1.08-1.15), stroke (HR 1.08; 95% CI 1.02-1.15), dementia (HR 1.19; 95% CI 1.12-1.26), and LLD (HR 1.14; 95% CI 1.09-1.18). Individuals with both shorter LTL and lower BCS faced significantly increased risks of age-related brain diseases (HR 1.11; 95% CI 1.07-1.16) and individually for stroke (HR 1.10; 95% CI 1.02-1.19), dementia (HR 1.17; 95% CI 1.08-1.28), and LLD (HR 1.13; 95% CI 1.07-1.19). Conversely, individuals with higher BCS within the shortest LTL group did not show a significant increase in risk of any age-related brain diseases. MR analyses did not identify causal relationships between LTL and these outcomes. DISCUSSION: Individuals with shorter LTL are at increased risk of stroke, dementia, and LLD. Improved modifiable risk factor profiles seem to mitigate the impact of LTL on these diseases. Future research should explore the effectiveness of lifestyle interventions in mitigating adverse biological aging effects on brain health.
引用
- Kimball TN, Prapiadou S, Tack RWP, et al. Association of Leucocyte Telomere Length With Stroke, Dementia, and Late-Life Depression: The Role of Modifiable Risk Factors. Neurology. 2025. PMID: 40499086. doi:10.1212/WNL.0000000000213794
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。